Enterobacter cloacae

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
4
0 0 0 0
Azithromycin
-
-
-
- -
Aztreonam
82
83
87
85 85
Cefazolin
1
0
0
0 0
Cefepime
+
+
+
+ +
Ceftazidime
85
83
85
85 84
Ceftriaxone
79
81
79
73 72
Cefuroxime
5
0
0
0 0
Ciprofloxacin
98
97
97
94 95
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
-
89
89
+ +
Erythromycin
-
-
-
- -
Gentamicin
98
98
98
96 97
Imipenem
99
100
93
97 93
Levofloxacin 98 98 99 98 97
Meropenem + 100 100 100 99
Moxifloxacin + + + + +
Nitrofurantoin 28& 28& 29& 31& 34&
Oxacillin/Naf - - - - -
Penicillin - - - - -
Piperacillin 74 77 78 + +
Piperacillin/tazo 87 89 90 90 90
Ticarcillin/Clav + + + + +
Tobramycin 98 98 98 96 97
TMP/SMX 86 91 93 89 91
Unasyn/Aug 7 0 0 0 0
Vancomycin - - - - -
       
# Tested 190 289 239 274 268

Comments:  

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections